News
September 22, 2011
Manhattan/Torcon Tops Out U.S. Department of Defense Biocontainment Facility
On September 22, 2011, the U.S. Army Corps of Engineers and the Manhattan/Torcon
building team celebrated the “Topping Out” of the U.S. Army Medical Research Institute
of Infectious Diseases (USAMRIID) Replacement facility at Fort Detrick, Maryland.
USAMRIID is the largest, most complex biocontainment facility ever designed for the
U.S. Department of Defense. The joint-venture team of Manhattan Construction Co. of
Washington, D.C. and Torcon, Inc. of Red Bank, N.J. is constructing the $518 million
project.
When the six-story 835,000-square-foot research facility is complete, the new
USAMRIID building will house the largest concentration of Biosafety Level 3 and BSL 4
laboratory space in the Department of Defense. The BSL laboratory spaces employ many
technical enhancements to protect researchers and to enhance their study of emerging
biological threats, such as Ebola. The containment labs, for which USAMRIID is known,
allow the Institute to safely work with highly hazardous pathogens to carry out its
research mission.
In addition to its primary focus on protecting U.S. military personnel, USAMRIID also
plays a critical role in the status of the country’s emergency preparedness. The Institute
is a cornerstone of the U.S. biodefense strategy and is also a key component of the
National Interagency Biodefense Campus at Fort Detrick.
At the Topping Out ceremony, MG James K. Gilman, USAMRMC commanding general,
called the partnership between Manhattan and Torcon, the U.S. Army Health Facility
Planning Agency, the Corps of Engineers and USAMRIID a great example of teamwork.
The General added, “I have high hopes that the spirit of cooperation you’ve established
will continue long after the construction is complete.”
The building is scheduled to be completed in late 2014. The USAMRIID project is LEED®-
registered and designed to meet LEED Silver certification. The project architect is a joint
venture of CUH2A, a subsidiary of HDR, Inc., and Smith Carter.